上海復旦(01385.HK):復旦大學委託上海華嶺進行一項28nm記憶體模擬控制IP的BTS測試項目全套測試服務
格隆匯9月23日丨上海復旦(01385.HK)發佈公吿,於2021年9月23日,上海華嶺與復旦大學訂立一項新技術服務合同。復旦大學同意委託上海華嶺進行一項28nm記憶體模擬控制IP的BTS測試項目的全套測試服務。人民幣270萬元費用於新技術服務合同簽署後30天內一次支付。
上海華嶺為公司持有50.3%股份權益的附屬公司,其業務為提供集成電路測試服務;設計、開發及銷售集成電路的測試軟件;探針卡製造以及提供集成電路技術開發及技術諮詢。
IC產品及的測試服務為集團兩個報吿經營分部之一,多年來為集團的收入及業績提供良好貢獻。董事認為訂立新技術服務合同除可讓上海華嶺維持客户基礎,提高測試服務水平及累積實務經驗外,更有助集團增加收入及盈利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.